Immune response drives outcomes in prostate cancer: implications for immunotherapy

Immune response drives outcomes in prostate cancer: implications for immunotherapy

The heterogeneity of the immune microenvironment leads to different responses in immune checkpoint blockade therapy. We aimed to propose a robust molecular classification system to investigate the relevance of the immune microenvironment subtype and prognosis of prostate cancer patients, as well as...

Full description

Bibliographic Details
Main Authors: Jialin Meng, Yujie Zhou, Xiaofan Lu, Zichen Bian, Yiding Chen, Jun Zhou, Li Zhang, Zongyao Hao, Meng Zhang, Chaozhao Liang
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Molecular Oncology
Subjects:
immune checkpoint blockade therapy
immune molecular subclassification system
immunotherapy
non‐negative matrix factorization
prostate cancer
Online Access:https://doi.org/10.1002/1878-0261.12887

Internet

https://doi.org/10.1002/1878-0261.12887

Similar Items